Distribution and drug resistance of pathogens in burn patients in China from 2006 to 2019

doi:10.12998/wjcc.v9.i10.2228

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3545)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

145

WORD

126

HTML

1601

Figures (1-3)

151

Tables (1-3)

174

Sum=2197

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

407

Download

941

Sum=1348

Apr 6, 2021 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Apr 6, 2021; 9(10): 2228-2237
Published online Apr 6, 2021. doi: 10.12998/wjcc.v9.i10.2228

Table 3 Comparison of antimicrobial resistance of major pathogens in burn patients, n (%)

			2006-2011		2012-2019	χ²	P value
		Strain	Resistant strains	Strain	Resistant strains	χ²	P value
Staphylococcus aureus	Oxacillin	281	191 (67.97)	1445	545 (37.72)	88.0448	< 0.001
	Vancomycin	281	0 (0.00)	1445	0 (0.00)	NA	NA
Enterococcus	Vancomycin	115	13 (11.30)	492	6 (1.22)	31.265	< 0.001
Pseudomonas aeruginosa	Cefepime	173	109 (63.01)	960	369 (38.44)	36.2767	< 0.001
	Ceftazidime	173	78 (45.09)	960	334 (34.79)	6.7138	0.001
	Imipenem	173	79 (45.67)	960	390 (40.63)	1.5347	0.215
	Levofloxacin	173	88 (50.87)	960	349 (36.35)	13.0306	< 0.001
Acinetobacter baumannii	Cefepime	203	181 (89.16)	360	261 (72.50)	21.3591	< 0.001
	Ceftazidime	203	173 (85.22)	360	255 (70.83)	14.7418	< 0.001
	Imipenem	203	135 (66.50)	360	233 (64.72)	0.1817	0.67
	Levofloxacin	203	177 (87.19)	360	186 (51.67)	71.5236	< 0.001

NA: Not available.

Citation: Chen H, Yang L, Cheng L, Hu XH, Shen YM. Distribution and drug resistance of pathogens in burn patients in China from 2006 to 2019. World J Clin Cases 2021; 9(10): 2228-2237
URL: https://www.wjgnet.com/2307-8960/full/v9/i10/2228.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i10.2228